Cost-effectiveness analysis of preoperative treatment of acromegaly with somatostatin analogue on surgical outcome

Published: 20 August 2015
Author(s): Luis Margusino-Framiñán, Sonia Pertega-Diaz, Lara Pena-Bello, Susana Sangiao-Alvarellos, Elena Outeiriño-Blanco, Francisco Pita-Gutierrez, Salvador Pita-Fernandez, Fernando Cordido
Section: Original Article

There is no uniform standard of care for acromegaly. Due to the high costs involved, steps must be taken to ensure the cost-effective delivery of treatment.